2023 Global Life Sciences Outlook
Innovating and collaborating for tomorrow
The COVID-19 pandemic magnified the importance of digital advances as companies raced to meet the demand for new testing, vaccines, and treatments to combat the pandemic.
Will Computer Software Assurance (CSA) improve product quality and patient safety?
While technology and computerised systems have advanced greatly in that time, the life sciences industry has been slow to amend Computer System Validation principles in in line with advancements.
Measuring the return from pharmaceutical innovation 2021
Since 2010, we have been tracking the returns on R&D investment that the largest biopharma companies might expect to achieve from their late-stage pipelines. This year’s analysis shows a large improvement in the average internal rate of return on pharmaceutical innovation for our combined cohort.
The future unmasked
Predicting the future of healthcare and life sciences in 2025
What does the future hold for the life sciences and healthcare industry? Our latest predictions report looks ahead to the year 2025 to help you see what’s coming and to keep your organisation moving forward.